Correlates of severity in a clinical staging model of schizophrenia: a cross-sectional study among 158 subjects

Correlates of severity in a clinical staging model of schizophrenia: a cross-sectional study among 158 subjects

Abstract Background Clinical staging has been widely used to predict and optimize the treatment of medical disorders. Different models have been proposed to map the development, progression, and extension of psychiatric disorders over time, mainly for schizophrenia. The primary objective of this stu...

Bibliografski detalji
Glavni autori:	Fatima Hamieh, Souheil Hallit, Chadia Haddad, Sahar Obeid, Francois Kazour
Format:	Članak
Jezik:	English
Izdano:	BMC 2023-09-01
Serija:	BMC Psychiatry
Teme:	Staging Schizophrenia Psychosis Mood Antipsychotics
Online pristup:	https://doi.org/10.1186/s12888-023-05144-6

Slični predmeti

Benzodiazepines and Mood Stabilizers in Schizophrenia Patients Treated with Oral versus Long-Acting Injectable Antipsychotics—An Observational Study
od: Ana Aliana Miron, i dr.
Izdano: (2023-01-01)

Exploring negative symptoms heterogeneity in patients diagnosed with schizophrenia and schizoaffective disorder using cluster analysis
od: Feten Fekih-Romdhane, i dr.
Izdano: (2023-08-01)

Global Neuropsychopharmacological Prescription Trends in Adults with Schizophrenia, Clinical Correlates and Implications for Practice: A Scoping Review
od: Jiangbo Ying, i dr.
Izdano: (2023-12-01)

Applying a clinical staging model in patients affected by schizophrenia spectrum disorder
od: Renato de Filippis, i dr.
Izdano: (2024-07-01)

Peripheral Lipid Signatures, Metabolic Dysfunction, and Pathophysiology in Schizophrenia Spectrum Disorders
od: Sally Wu, i dr.
Izdano: (2024-08-01)

Novel Compounds in the Treatment of Schizophrenia—A Selective Review
od: Evangelia Maria Tsapakis, i dr.
Izdano: (2023-08-01)

Improving treatment of women with schizophrenia: a review of the recent literature
od: Alexandre González-Rodríguez, i dr.
Izdano: (2023-12-01)

The relationship between combined antipsychotic use and clinical features in schizophrenia spectrum patients treated in inpatient ward: A retrospective study
od: U. Baklaci
Izdano: (2021-04-01)

The Tower of Babel in Psychiatry
od: Orestis Giotakos
Izdano: (2023-12-01)

Antipsychotic prescribing choices in patients with First Episode Psychosis
od: J. Fallon, i dr.
Izdano: (2022-06-01)

Medication Dosage Impact on Mortality in Old-Age Individuals with Schizophrenia: A National Cohort Study
od: Jia-Ru Li, i dr.
Izdano: (2024-01-01)

Weight Gain, Mental Symptoms and Self-Esteem in Patients with Schizophrenia
od: Sevde Öner, i dr.
Izdano: (2022-12-01)

Neutrophil/lymphocyte ratio is increased in the acute phase of schizophrenia and regardless the use and types of antipsychotic drugs
od: Yali Zheng, i dr.
Izdano: (2024-12-01)

Metformin in the management of antipsychotic-induced weight gain – why the ‘weight’?
od: Ita Fitzgerald, i dr.
Izdano: (2024-11-01)

Alternative initiation regimen of paliperidone palmitate long-acting injectable
od: I.E. Menendez Gil, i dr.
Izdano: (2022-06-01)

The challenges in schizophrenia treatment in real-life: The uncomfortable truth
od: E. Rancans
Izdano: (2021-04-01)

Study of factors associated with obesity in patients using antipsychotics in schizophrenia
od: Vishalakshi Patnam, i dr.
Izdano: (2024-12-01)

The Effect of Antipsychotics on Cognition in Schizophrenia—A Current Narrative Review
od: Petru Fabian Lungu, i dr.
Izdano: (2024-04-01)

Medication adherence in schizophrenia: The role of family supervision, dosage frequency and medication knowledge
od: Jombo HE, i dr.
Izdano: (2015-08-01)

Concepts for selection and utilization of psychiatric medications in pregnancy
od: P. Brittany Vickery, PharmD, BCPS, BCPP, CPP
Izdano: (2023-12-01)

Effects of long-term therapy with quetiapine and olanzapine on parameters of immunity and cytokine levels in patients with schizophrenia
od: O. Lobacheva, i dr.
Izdano: (2021-04-01)

Epigenetic Targets in Schizophrenia Development and Therapy
od: Agnieszka Wawrzczak-Bargieła, i dr.
Izdano: (2023-03-01)

Polypharmacy Management of Antipsychotics in Patients with Schizophrenia
od: Hiroyuki Kamei
Izdano: (2022-11-01)

Adjunctive antidepressive pharmacotherapy in schizophrenia patients
od: M. Zink
Izdano: (2021-04-01)

Anticholinergic syndrome in a patient with schizophrenia
od: O. Marco Estrada, i dr.
Izdano: (2022-06-01)

Factors associated with real-world functioning in first stages of schizophrenia disorder
od: C. Martínez-Cao, i dr.
Izdano: (2021-04-01)

Efficacy of Lurasidone in First-Episode Psychosis: Patient Phenotypes, Dosage, and Recommendations from an Expert Panel
od: Miquel Bernardo, i dr.
Izdano: (2025-01-01)

Tolerability of cariprazine in the early stage of schizophrenia: A pooled, post-hoc analysis of 4 phase ii/iii double-blind placebo-controlled trials
od: Z.B. Dombi, i dr.
Izdano: (2021-04-01)

Involuntary medication treatment of schizophrenia in the inpatient setting
od: Courtney A. Iuppa, PharmD, BCPP
Izdano: (2024-12-01)

Ultra-treatment-resistant Schizophrenia. A case report
od: A. Osca Oliver, i dr.
Izdano: (2022-06-01)

Biomarkers of thrombotic tendency in schizophrenia and related psychoses: Implications for the potential usefulness of anticoagulants in schizophrenia
od: Kara B. Miecznikowski, i dr.
Izdano: (2024-12-01)

Introducing a new severity specifier for schizophrenia: conceptual framework and clinical implications
od: Ary Gadelha, i dr.
Izdano: (2024-12-01)

Effectiveness of antipsychotics in schizophrenia with comorbid substance use disorder
od: M. Lähteenvuo, i dr.
Izdano: (2021-04-01)

Analysis of Oral versus Long-acting Injectable Antipsychotics in the Maintenance of Schizophrenia
od: O. Vasiliu
Izdano: (2022-06-01)

Atypical antipsychotics in the treatment of schizophrenia
od: Swiss Medical Weekly
Izdano: (2003-02-01)

Stigmatisation of schizophrenia, psychosis and autism in flemish newspapers
od: E. Thys, i dr.
Izdano: (2021-04-01)

Medication and symptom severity in schizophrenia patients in COVID-19 pandemic: A cross-sectional study
od: Asli Kazgan, i dr.
Izdano: (2021-09-01)

Real-world treatment patterns and outcomes in patients initiating lurasidone for the treatment of schizophrenia in Europe
od: A. Jones, i dr.
Izdano: (2022-06-01)

The psychopathological trajectories to delusion in Schizophrenia: the affective and schizotypal pathways
od: D. Borrelli, i dr.
Izdano: (2022-06-01)

The Neurobiological Underpinnings of Obsessive-Compulsive Symptoms in Psychosis, Translational Issues for Treatment-Resistant Schizophrenia
od: Licia Vellucci, i dr.
Izdano: (2023-08-01)